GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Clinical trial NCT06077903 · TERMINATED
Trial details
- NCT number
- NCT06077903
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2025-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.